**Closure of my websites askdrray.com and nethealthbook.com**

These websites will be taken down on **April 30, 2025** and no further updates will be provided.
I hope you enjoyed the content of these websites. You can continue to read Dr. Schilling’s blogs which I publish daily on Quora

My home page there is: ** https://www.quora.com/profile/Ray-Schilling**

Click on this: Under my image there is a heading “Profile”. Right underneath this you find a search box entitled “search content”. Type in any term you are interested in. You will get several answers I have written (I have written more than 15,000 answers).

On Quora you can also write comments that I will answer.

Thank you for your trust in the past. Ray Schilling, MD
**Closure of my websites askdrray.com and nethealthbook.com**

These websites will be taken down on **April 30, 2025** and no further updates will be provided.
I hope you enjoyed the content of these websites. You can continue to read Dr. Schilling’s blogs which I publish daily on Quora

My home page there is: ** https://www.quora.com/profile/Ray-Schilling**

Click on this: Under my image there is a heading “Profile”. Right underneath this you find a search box entitled “search content”. Type in any term you are interested in. You will get several answers I have written (I have written more than 15,000 answers).

On Quora you can also write comments that I will answer.

Thank you for your trust in the past. Ray Schilling, MD
Jun
01
2004

New Antibody Treatment For Colon Cancer

The drug Cetuximab landed Martha Stewart in the middle of an insider-trading scandal back in December of 2001. Inside information stated that the FDA had turned down the application for this drug in December. However, now there is good news for patients.

The FDA has recently approved the drug, also known as Erbitux. The medication offers treatment for patients with metastatic colorectal cancer who are not tolerating chemotherapy with irinotecan. The most innovative feature of Erbitux is the fact, that it is the first-of-its-kind antibody that inhibits a specific protein, which in turn stops cell division of cancer cells. Clinical trials that were done in Europe consisted of testing stage III colorectal cancer patients with irinotecan (chemotherapeutic agent) alone or in combination with Cetuximab (equivalent of Erbitux). The survival advantage was almost 9 months better in the combination group. Cetuximab alone also had a certain effect, but was not as good as the combination therapy. In the next few years more of these new antibody therapies will be tested in clinical trials to check out the safety and the effectiveness in various cancer types.

New Antibody Treatment For Colon Cancer

New Antibody Treatment For Colon Cancer

More info on colon cancer treatment: http://nethealthbook.com/cancer-overview/colon-cancer/colon-cancer-treatment/

Based on a paper by Harris M – Lancet Oncol – 01-MAY-2004; 5(5): 292-302: “Monoclonal antibodies as therapeutic agents for cancer”.

Last edited October 26, 2014

About Ray Schilling

Dr. Ray Schilling born in Tübingen, Germany and Graduated from Eberhard-Karls-University Medical School, Tuebingen in 1971. Once Post-doctoral cancer research position holder at the Ontario Cancer Institute in Toronto, is now a member of the American Academy of Anti-Aging Medicine (A4M).